Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Common antidepressant may change brain differently in depressed and non-depressed people

  • Extra hour of screen time per day associated with poorer GCSE grades

  • How protein tangles accumulate in brain, cause neurological disorders

  • Artificial intelligence authors crowdsourced interactive fiction

  • Neighbors, but not classmates

  • IV administration of endothelin B receptor drug reduces memory loss, oxidative stress in Alzheimer's disease

  • Highly effective seasickness treatment on the horizon

  • Making effective use of voluntary help

  • Tracking down the causes of Alzheimer's

  • New model of cognitive flexibility gives insight into autism spectrum disorder

  •